Explore
Trendline
Neuraptive Therapeutics Announces Key Leadership Appointments for Commercialization
Neuraptive Therapeutics Announces Key Leadership Appointments for Commercialization
Read More
Trendline
Neuraptive Therapeutics Appoints New Leadership to Drive Commercialization Efforts
Neuraptive Therapeutics Appoints New Leadership to Drive Commercialization Efforts
Read More
Trendline
IGC Pharma's Alzheimer's Drug Trial Progress Boosts Stock Target
IGC Pharma's Alzheimer's Drug Trial Progress Boosts Stock Target
Read More
Trendline
Savara Announces Leadership Transition as CFO Steps Down for Health Reasons
Savara Announces Leadership Transition as CFO Steps Down for Health Reasons
Read More
Trendline
Zai Lab's TIVDAK Approved in China for Cervical Cancer Treatment
Zai Lab's TIVDAK Approved in China for Cervical Cancer Treatment
Read More
Trendline
Soley Therapeutics Appoints Berthil Clasen as Chief Business Officer to Lead Strategic Growth
Soley Therapeutics Appoints Berthil Clasen as Chief Business Officer to Lead Strategic Growth
Read More
Trendline
BPGbio Appoints Eric J. Nestler as Chair of Scientific Advisory Board
BPGbio Appoints Eric J. Nestler as Chair of Scientific Advisory Board
Read More
Trendline
Adaptyx Biosciences Unveils Continuous Cortisol Monitoring Technology at ADA
Adaptyx Biosciences Unveils Continuous Cortisol Monitoring Technology at ADA
Read More
Trendline
AllerGene AI Therapeutics Strengthens Board with Appointment of Gad Berdugo
AllerGene AI Therapeutics Strengthens Board with Appointment of Gad Berdugo
Read More
Trendline
Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors, Signaling Strategic Growth
Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors, Signaling Strategic Growth
Read More
Trendline
Antengene Unveils Preclinical Data on ATG-207 for Autoimmune Disease Treatment
Antengene Unveils Preclinical Data on ATG-207 for Autoimmune Disease Treatment
Read More
Trendline
Novo Nordisk CEO Explores Longevity and Aesthetics Amidst Share Decline
Novo Nordisk CEO Explores Longevity and Aesthetics Amidst Share Decline
Read More